pharmaphorum

DECEMBER 23, 2022

price tag of $475,000 when it was first launched in 2017 – and it becomes apparent that these may not be desirable treatment options for every patient and in every setting. Add to this the considerable cost of these medications – the first approved CAR-T, Novartis’ Kymriah (tisagenlecleucel), had a U.S.

Side effects 52

Side effects Patients Medical Medicine 52

Contrarian Sales Techniques

JANUARY 23, 2024

So, strap yourselves in because I'm here to peel back the CNPR curtain, tell you the good, the bad, and the pharmaceutical, and equip you with the intel you need to crack the code to pharmaceutical sales success. It delves into the science behind the drugs, equipping you with knowledge of anatomy, physiology, and therapeutic areas.

Pharmaceutical Sales 52

Pharmaceutical Sales Pharmaceutical Sales Ethics 52

Rep-Lite

MARCH 21, 2024

It’s safe to say we have a pretty good idea about what we’re doing. Experienced medical sales reps who specialize in medical products or therapeutic areas may receive higher compensation due to their expertise and ability to provide value-added services to clients. Contact A Rep-Lite Professional Today For More Information!

Medical sales 52

Medical sales Medical sales reps Medical Sales 52

European Pharmaceutical Review

DECEMBER 27, 2023

Studies have since demonstrated significantly reduced CAR-associated CRS and other toxicities without jeopardising therapeutic yield and outcomes; 9 both G-CSF and tocilizumab are now part of daily practice in CART-cell therapy. This is in addition to its considerable price tag.

Manufacturing 83

Manufacturing Food and Drug Administration Patients Pharma 83

Pharmaceutical Technology

NOVEMBER 30, 2022

However, there has recently been a boom in interest and research in anti-obesity therapeutics. Anti-obesity therapeutic landscape. The company’s weight loss drug Saxenda (liraglutide) won an approval for chronic weight management in December 2014, and Wegovy (semaglude) got the same tag in 2021. compared to a 5.1%

Medical 105

Medical Manufacturing Insurance Side effects 105

Pharmaceutical Technology

NOVEMBER 30, 2022

However, there has recently been a boom in interest and research in anti-obesity therapeutics. Anti-obesity therapeutic landscape. The company’s weight loss drug Saxenda (liraglutide) won an approval for chronic weight management in December 2014, and Wegovy (semaglude) got the same tag in 2021. compared to a 5.1%

Medical 98

Medical Manufacturing Insurance Side effects 98

Pharma Marketing Network

JUNE 8, 2020

Good morning, Dave. I mean, you know, there has obviously been a lot of breakthrough biologics and different therapeutics like around cancers and things like that, that have high price tags because maybe they don’t have as big a market as you know, something’s wrong, you know blood pressure medication.

Healthcare 40

Healthcare Healthcare Marketing Pharma 40